Consensus $2.88B. Consolidated Adjusted EBITDA range of $555 million to $585 million, compared to its previous guidance range of $545 million to $595 million. Guidance range includes the direct impact of tariffs, as currently outlined, which is expected to be immaterial. “Arcosa (ACA) remains on track for strong growth in 2025. Our U.S.-focused operations are well-aligned with long-term infrastructure and power market tailwinds. Given healthy overall demand in our growth businesses along with solid backlog visibility in our cyclical businesses, we are tightening our guidance range while maintaining the mid-point, to reflect increased confidence in our overall outlook,” concluded Mr. Carrillo.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACA:
